Your browser doesn't support javascript.
loading
Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer: Post Hoc Utility of a Mean Absolute Dose Deviation Penalty Score.
Heymann, Steve; Dipasquale, Giovanna; Nguyen, Nam P; San, Meymey; Gorobets, Olena; Leduc, Nicolas; Verellen, Dirk; Storme, Guy; Van Parijs, Hilde; De Ridder, Mark; Vinh-Hung, Vincent.
Afiliação
  • Heymann S; Strasbourg Oncologie Liberale, Strasbourg, France.
  • Dipasquale G; Geneva University Hospitals, Geneva, Switzerland.
  • Nguyen NP; Department of Radiation Oncology, Howard University, Washington, DC, USA.
  • San M; Khmer Soviet Friendship Hospital, Cambodia.
  • Gorobets O; University Hospital of Martinique, Site Clarac, Martinique, France.
  • Leduc N; University Hospital of Martinique, Site Clarac, Martinique, France.
  • Verellen D; Medical Physics, Faculty of Medicine and Health Sciences, Iridium Kankernetwerk and University of Antwerp, Wilrijk, Belgium.
  • Storme G; Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
  • Van Parijs H; Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
  • De Ridder M; Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
  • Vinh-Hung V; Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Technol Cancer Res Treat ; 19: 1533033820947759, 2020.
Article em En | MEDLINE | ID: mdl-32940569
BACKGROUND: A 2-level factorial pilot study was conducted in 2007 just before starting a randomized clinical trial comparing tomotherapy and conventional radiotherapy (CR) to reduce cardiac and pulmonary adverse effects in breast cancer, considering tumor laterality (left/right), target volume (with/without nodal irradiation), surgery (tumorectomy/mastectomy), and patient position (prone/supine). The study was revisited using a penalty score based on the recently developed mean absolute dose deviation (MADD). METHODS: Eight patients with a unique combination of laterality, nodal coverage, and surgery underwent dual tomotherapy and CR treatment planning in both prone and supine positions, providing 32 distinct combinations. The penalty score was applied using the weighted sum of the MADDs. The Lenth method for unreplicated 2-level factorial design was used in the analysis. RESULTS: The Lenth analysis identified nodal irradiation as the active main effect penalizing the dosimetry by 1.14 Gy (P = 0.001). Other significant effects were left laterality (0.94 Gy), mastectomy (0.61 Gy), and interactions between left mastectomy (0.89 Gy) and prone mastectomy (0.71 Gy), with P-values between 0.005 and 0.05. Tomotherapy provided a small reduction in penalty (reduction of 0.54 Gy) through interaction with nodal irradiation (P = 0.080). Some effects approached significance with P-values > 0.05 and ≤ 0.10 for interactions of prone × mastectomy × left (0.60 Gy), nodal irradiation × mastectomy (0.59 Gy), and prone × left (0.55 Gy) and the main effect prone (0.52 Gy). CONCLUSIONS: The historical dosimetric analysis previously revealed the feasibility of tomotherapy, but a conclusion could not be made. The MADD-based score is promising, and a new analysis highlights the impact of factors and hierarchy of priorities that need to be addressed if major gains are to be attained.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Radioterapia de Intensidade Modulada Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Technol Cancer Res Treat Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Radioterapia de Intensidade Modulada Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Technol Cancer Res Treat Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França